Description

PT-141, also known as Bremelanotide, is a synthetic melanocortin receptor agonist widely researched for its centrally mediated influence on arousal-associated signaling and motivational behavior. Unlike vascular-acting compounds, PT-141 is studied for its action on melanocortin receptors (MC3R and MC4R) in the central nervous system, positioning it as a unique research tool in neuroendocrine and behavioral studies. Research into PT-141 frequently explores its role in sexual motivation pathways, hypothalamic signaling networks, and peptide-mediated behavioral modulation. Its distinct mechanism of action makes it particularly valuable for laboratories investigating central arousal pathways, melanocortin system biology, and neuropeptide behavioral research.